India has been famous for the pharmacy due to the very definite role that it played in the pharmaceutical world, especially in producing generics. In 2024, the nation continues to lead as the primary generic drug producers not only in the home market but also globally, providing cheap but quality equivalents of branded drugs. The generic drug industry in India is the largest in volume worldwide and manufactures more than 60 percent of all the vaccines used globally and nearly 20 percent of the world's total generic medicines by volume. This makes India a critical supplier to many countries, particularly in emerging markets and low-income regions. Indian generic pharma markets are reportedly growing very phenomenally during the last decade with cost-effective demand. As the growth in health costs is highly observed in developed economies across the world, affordability and access to medicines as offered by generics assume the vital role. Generic drug firms from India have an advantage in a strong and well-established pharmaceutical manufacturing infrastructure provided by a skilled workforce, a high scale of production, and favorable regimes in terms of regulation.

The Indian industries are regulated by the Central Drugs Standard Control Organization (CDSCO) within the country, but the international regulatory bodies like U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) do regulate the Indian...